Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Julijan Kabiljo

Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis

Journal for ImmunoTherapy of Cancer

English

Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy

English

Related publications

Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation

Cancer Research

Oncology

2004

English

Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1

English

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

English

Histone Deacetylase 9 Deficiency Protects Against Effector T Cell-Mediated Systemic Autoimmunity

Journal of Biological Chemistry

English

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

Pharmacotherapy

Pharmacology

2015

English

Histone Deacetylase Inhibitors Modulate Interleukin 6-Dependent CD4+T Cell Polarizationin Vitroandin Vivo

Journal of Biological Chemistry

English

Histone Deacetylase Inhibition by Valproic Acid Down-Regulates C-Flip/Cash and Sensitizes Hepatoma Cells Towards CD95- And TRAIL Receptor-Mediated Apoptosis and Chemotherapy

English

Histone Deacetylase Inhibitors Valproic Acid and Depsipeptide Sensitize Retinoblastoma Cells to Radiotherapy by Increasing H2AX Phosphorylation and P53 Acetylation-Phosphorylation

International Journal of Oncology

Cancer Research

Oncology

2010

English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Julijan Kabiljo

Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis

Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy

Related publications

Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation

Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1

Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro

Histone Deacetylase 9 Deficiency Protects Against Effector T Cell-Mediated Systemic Autoimmunity

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat

Histone Deacetylase Inhibitors Modulate Interleukin 6-Dependent CD4+T Cell Polarizationin Vitroandin Vivo

Histone Deacetylase Inhibition by Valproic Acid Down-Regulates C-Flip/Cash and Sensitizes Hepatoma Cells Towards CD95- And TRAIL Receptor-Mediated Apoptosis and Chemotherapy

Histone Deacetylase Inhibitors Valproic Acid and Depsipeptide Sensitize Retinoblastoma Cells to Radiotherapy by Increasing H2AX Phosphorylation and P53 Acetylation-Phosphorylation

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors